⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 8, 2024AmyloidOpen Access

International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction

Sergi Yun Giovanni Palladini Lisa Anderson Eve Cariou Ronnie Wang Franca S. Angeli Ben Ebede Pablo García‐Pavía

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed cause of heart failure (HF).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yun et al. (2024) studied this question.

synapsesocial.com/papers/68e590f7b6db64358752ca5c https://doi.org/10.1080/13506129.2024.2398446

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Prevalence of transthyretin amyloid cardiomyopathy in an unselected cohort with heart failure with preserved ejection fractioncohort · 2025 · 7 citations
2Hidden overlap between heart failure with preserved ejection fraction and transthyretin amyloid cardiomyopathy: Why it matters and how to avoid missing itreview · 2026
3Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fractionother · 2015 · 1,183 citations
4Transthyretin amyloidosis prevalence and characteristics in Korean patients with heart failure with preserved or mildly reduced ejection fractions2024
5Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?review · 2020 · 7 citations